See leaflet
Epixtie®
pralatrexate
Indications
- Treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
Presentations
- (COMING SOON) 20 mg x 1 vial (solution for injection)
- (COMING SOON) 20 mg x 1 vial (solution for injection)